Last $1.40 USD
Change Today -0.03 / -2.10%
Volume 55.5K
ARQL On Other Exchanges
Symbol
Exchange
NASDAQ GM
Frankfurt
As of 9:49 AM 07/11/14 All times are local (Market data is delayed by at least 15 minutes).

Audit Committee* - arqule inc (ARQL)

Name (Connections)Board RelationshipsTitleKey Developments
Patrick Zenner MBA 111 RelationshipsChairman, Member of Audit Committee and Member of Compensation, Nominating & Governance Committee 
Timothy Barabe 26 RelationshipsIndependent Director and Chairman of Audit Committee 
William Messenger D. Min. 16 RelationshipsDirector, Chairman of Compensation, Nominating & Governance Committee and Member of Audit Committee 

Compensation Committee* - arqule inc (ARQL)

Name (Connections)Board RelationshipsTitle
Michael Loberg Ph.D. 21 RelationshipsDirector, Member of Science Committee and Member of Compensation, Nominating & Governance Committee
William Messenger D. Min. 16 RelationshipsDirector, Chairman of Compensation, Nominating & Governance Committee and Member of Audit Committee
Patrick Zenner MBA 111 RelationshipsChairman, Member of Audit Committee and Member of Compensation, Nominating & Governance Committee
ARQL Compensation vs. Industry
489.3K
374.3K
Chief Executive Officer
413.9K
274.0K
Chief Financial Officer
Share price activity for ARQULE INC (ARQL)
52 Week Price Performance
ARQL
Industry Average

Nominating Committee* - arqule inc (ARQL)

Name (Connections)Board RelationshipsTitleKey Developments
Patrick Zenner MBA 111 RelationshipsChairman, Member of Audit Committee and Member of Compensation, Nominating & Governance CommitteeArQule Inc. Announces the Resignation of Thomas Chan as Chief Scientific Officer Effective on November 10, 2012
11/8/12
William Messenger D. Min. 16 RelationshipsDirector, Chairman of Compensation, Nominating & Governance Committee and Member of Audit CommitteeArQule Inc. Appoints Susan L. Kelley, M.D. to the Board of Directors
04/28/11
Michael Loberg Ph.D. 21 RelationshipsDirector, Member of Science Committee and Member of Compensation, Nominating & Governance CommitteeNancy Simonian Tenders Resignation as A Director of the Arqule Inc.Effective on March 31, 2011
02/28/11

Corporate Governance Committee* - arqule inc (ARQL)

Name (Connections)Board RelationshipsTitle
Michael Loberg Ph.D. 21 RelationshipsDirector, Member of Science Committee and Member of Compensation, Nominating & Governance Committee
William Messenger D. Min. 16 RelationshipsDirector, Chairman of Compensation, Nominating & Governance Committee and Member of Audit Committee
Patrick Zenner MBA 111 RelationshipsChairman, Member of Audit Committee and Member of Compensation, Nominating & Governance Committee
ARQL and Competitor
Insiders vs. External
Board
6%
94%
ArQule Inc.
20%
80%
Curis, Inc.
7%
93%
Cytokinetics, Incorporated
29%
71%
Rigel Pharmaceuticals, Inc.
15%
85%
AVEO Pharmaceuticals, Inc.
40%
60%
CrystalGenomics, Inc.
Insiders
External Board Members

Advisory Committee* - arqule inc (ARQL)

Name (Board Relationships)/Title Board Affiliations
Werner Cautreels 47 Relationships
Member of Scientific Advisory Board
No other board affiliations
Gerard Evan 16 Relationships
Member of Scientific Advisory Board
No other board affiliations
Alfred Goldberg 76 Relationships
Member of Scientific Advisory Board
No other board affiliations
William Kaelin 147 Relationships
Member of Scientific Advisory Board
No other board affiliations
Chiang Li 35 Relationships
Chairman of Scientific Advisory Board
No other board affiliations
Arthur Pardee 25 Relationships
Member of Scientific Advisory Board
No other board affiliations
John Ryan 36 Relationships
Member of Scientific Advisory Board
No other board affiliations
Samuel Saks 69 Relationships
Member of Scientific Advisory Board
No other board affiliations
Daniel Von Hoff 604 Relationships
Member of Scientific Advisory Board
No other board affiliations
Robert Weinberg 94 Relationships
Member of Scientific Advisory Board
No other board affiliations
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ARQL:US $1.40 USD -0.03

ARQL Competitors

Market data is delayed at least 15 minutes.

Company Last Change
AVEO Pharmaceuticals Inc $1.42 USD +0.015
CrystalGenomics Inc 14,100 KRW 0.00
Curis Inc $1.72 USD +0.03
Cytokinetics Inc $4.35 USD +0.06
Rigel Pharmaceuticals Inc $3.34 USD -0.02
View Industry Companies
 

Industry Analysis

ARQL

Industry Average

Valuation ARQL Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 6.9x
Price/Book 1.6x
Price/Cash Flow NM Not Meaningful
TEV/Sales 1.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ARQULE INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.